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summaries of their data, the ability to track their progress through a questionnaire, 
and “thank you” messages for completing frequent questionnaires. Patients would 
be motivated to complete a daily dairy by seeing their overall percent compliance to 
date. Investigators should consider including these types of elements when design-
ing ePRO assessments for clinical trials.
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Objectives: Chronic spontaneous/idiopathic urticaria (CSU/CIU) is defined as the 
spontaneous appearance of itchy hives, angioedema, or both lasting ≥ 6 weeks. CSU/
CIU has a significant yet underestimated socioeconomic impact. The ASSURE-CSU 
study aims to identify and quantify the humanistic and economic burden of CSU/
CIU. Here we present Canadian specific data on utility values. MethOds: The study 
included a retrospective medical record abstraction, a cross-sectional PRO survey, 
and 7day diary of patients with CSU/CIU still symptomatic despite treatment, aged 
≥ 18 years, with disease persisting for ≥ 12 months. Patients completed the weekly 
Urticaria Activity Score (UAS7) and the EQ-5D-3L, a 2-part instrument comprised of 
the EQ-5D and the Visual Analog Scale (VAS). ED-5D-3L and VAS utility values were 
derived using a Canadian-specific scoring algorithm and a standard UK algorithm, 
respectively. Descriptive statistics were provided for these variables and stratified 
by disease severity. Results: The cohort included 99 patients with demographics 
in line with published characteristics of CSU/CIU patients and distributed across 
severity levels. The instrument was completed by 86 patients. Overall, the mean (SD) 
EQ-5D utility score was 0.7 (0.30); while the mean (SD) VAS utility score was 71.4 
(19.24). The dimensions of the EQ-5D-3L most affected where pain/discomfort and 
anxiety/depression with 61.4% and 40.9% of patients reporting moderate to extreme 
problems, respectively. Utility values decreased with increased disease severity for 
overall and dimension specific scores for both tools. cOnclusiOns: Compared to 
the average utility score of an average Canadian population (0.875), the results of 
this study at 0.7 demonstrate that CSU/CIU has a significant impact on patients’ 
health status and quality of life; with patients suffering from moderate to severe 
urticaria showing a greater impact on patients’ health state.
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Objectives: To assess the impact of pharmacists-led non-clinical interventions on 
knowledge, attitude and perception among pulmonary tuberculosis (PTB) patients 
in Pakistan. MethOds: A randomized controlled non-clinical trial was piloted on 
PTB patients under the supervision of registered pharmacists whereby PTB patients 
received educational non-clinical interventions regarding knowledge, attitude and 
perception on PTB. Self-administered research tool was used and demographic 
characteristics of the patients were determined by means of descriptive statistics. 
Data was analyzed by using SPSS 21.0. Comparison between trial group and con-
trol group was done with the help of inferential statistics. Results: Two hundred 
and eighty PTB patients were randomly chosen for the study i.e. one hundred and 
forty in each group. No significant differences were observed in either group for 
mean age, gender, education level, occupation and income whereas a significant 
improvement (p< 0.001) in the knowledge, attitude and perception was noted in the 
interventional group. cOnclusiOns: The pharmacist-led, non-clinical interven-
tion caused a significant improvement in PTB patients’ knowledge, attitude and 
perception scores. This study highlights pharmacists’ need and their significantly 
important role towards better patient care and education. These finding are con-
siderably useful for better disease management and control.
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Objectives: The purpose of this study was to examine the treatment outcomes of 
smear positive pulmonary TB cases registered in TB patients in Quetta. MethOds: 
Cross sectional retrospective cohort study was performed on TB patient in Fatima 
Jinnah chest hospital, Quetta. Retrospective medical records of smear-positive 
tuberculosis patients registered in first quarter of year 2012. Tuberculosis treatment 
outcomes were assessed according to WHO guidelines. The descriptive statistics 
was used to present the demographic and disease related information. Inferential 
statistics was used to the evaluation relationship among study variables. All anal-
yses were performed using SPSS 20.0. Results: Out of the 131 TB patients (67 
males and 64 females). Majority of the patients were in the age group 18-47 (73.7%). 
High percentage of the patients had successful treatment with treatment outcome 
“Completed” and ‟cured” were 65.5% (n= 74), whereas, death occurred in only 5.3% 
(n= 7) of patients. Demographic characteristics age was the only determine factor 
Objectives: Chronic spontaneous/idiopathic urticaria (CSU/CIU) is defined as the 
spontaneous appearance of itchy hives, angioedema, or both lasting ≥ 6 weeks. CSU/
CIU has a significant yet underestimated impact on patient’s work productivity. The 
ASSURE-CSU study aims to identify and quantify the humanistic and economic 
burden of CSU/CIU. Here we present Canadian data on work productivity and indi-
rect costs. MethOds: Patients with CSU/CIU, aged ≥ 18 years, with disease for ≥ 12 
months, symptomatic despite treatment were recruited in the study. Data were col-
lected on absenteeism and productivity loss via the Work Productivity and Activity 
Impairment –Specific Health problem (WPAI-SHP) questionnaire. The associated 
indirectly monthly costs were estimated based on 150hr/working week and average 
wage $CAD 25.62/hr. Descriptive statistics were provided and stratified by disease 
severity. Results: Cohort included 99 patients with a mean age of 50.8 years; 5 years 
mean disease duration, and a higher proportion of women (77.8%). Overall, 86 patients 
completed the WPAI with 54.7% employed (assessed separately from the WPAI, 46.5% 
had full-time employment). In the last 7 days, the mean proportion of time missed at 
work due to CSU/CIU was 6.0% (SD= 12.0%). The greatest percentage of time missed 
due to CSU/CIU was reported in moderate and severe patients (8.9% and 10.6%, respec-
tively). The mean proportion of overall work impairment due to CIU/CSU was 30.6% 
(SD= 27%). Total indirect monthly cost of work productivity loss was estimated to be 
a mean (SD) of $1,177 per patient in full-time employment. The overall indirect costs 
increased with disease severity. cOnclusiOns: This Canadian-specific analysis from 
ASSURE-CSU suggests that almost all patients in employment are affected at work by 
their disease, either through absenteeism or reduced productivity at work resulting 
in significant economic impact for employers and society.
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Objectives: Compare healthcare resource utilization of patients with severe 
asthma and elevated blood eosinophils (EOS) versus normal EOS. MethOds: 
Asthma patients were extracted from EMRClaims+ database from Jan 2004-July 
2011. Date of asthma diagnosis was defined as the index date. The 12-month 
period following index was defined as ‘assessment’ period, with disease severity 
classified by factors such as medication use and lung function based on the newly 
published European Respiratory Society/American Thoracic Society guidelines. 
Patients with ‘severe’ asthma were classified as those with ‘elevated’ (≥ 400 cells/
µL) and ‘normal’ EOS (< 400 cells/µL). Patients were followed for a maximum 
period of 12 months after index to record all-cause hospitalizations, ER and out-
patient visits and associated costs. Mean hospitalizations, visits, and costs were 
compared using Wilcoxon signed rank test. Proportions were compared using Chi 
square tests. Logistic regression was conducted to assess the influence of elevated 
EOS on probability of incurring resource use after controlling for demographics 
and baseline comorbidities. Results: Of the 2,164 asthma patients identified, 
184 (9%) were concordant with guideline recommendation for medication use for 
severe asthma (Guideline-Concordant-Severe: GCS patients). Of these, 56 (30%) 
had elevated EOS. A significantly greater proportion of GCS patients with elevated 
EOS had admissions during follow-up compared to those with normal EOS (29% 
vs 13%, p= 0.013). GCS patients with elevated EOS had significantly greater mean 
monthly admissions compared to normal EOS patients (0.1 vs 0.02, p= 0.011) and 
8 times the hospitalization cost compared to the group with normal EOS [$834 
(SD:4403) vs. $106 (SD:336), p= 0.012]. Logistic regression showed that patients 
with elevated EOS had greater likelihood of admissions during follow-up (OR: 2.61, 
p= .033). cOnclusiOns: Among patients with severe asthma with treatments 
concordant with ERS/ATS guidelines, those with elevated EOS experienced more 
frequent hospital admissions and greater cost compared to those with normal EOS.
ReSPiRAtoRy-RelAted diSoRdeRS - PAtient-RePoRted outComeS &  
PAtient PRefeRenCe StudieS
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Objectives: Clinical trials for COPD are increasingly using electronic methods 
to collect patient-reported outcomes (ePRO). As use of this technology increases, 
it is important to consider patient preference in questionnaire design. This study 
examined patient preference for receiving real-time feedback while completing 
ePRO assessments. MethOds: A total of 103 patients with COPD were surveyed. 
Patients were asked to assume that they were using a handheld or tablet device to 
complete questionnaires as part of a clinical trial; they were then presented with 
example screens and asked about types of feedback they might receive on the 
device. Results: Patients ranged in age from 32 to 86 years and were 55% female. 
50% reported previous participation in a clinical trial. 59% reported that they would 
like to see a “thank you” screen at the end of each questionnaire. 81% thought 
it would be helpful or necessary to regularly receive a graph summarizing their 
responses. 81% preferred to see their progress as they completed a questionnaire; of 
these, 41% preferred a progress bar and “Question X of X” message and 47% preferred 
just the progress bar. 69% said they would like the first screen to summarize the 
questionnaire’s length and estimated completion time. Regarding feedback about 
daily diary compliance, 76% reported that a summary screen showing their percent 
compliance would motivate them to complete their diary each day. cOnclusiOns: 
Patients with COPD prefer to receive real-time feedback while completing ePRO 
assessments, and are motivated by compliance information. Specifically, they prefer 
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teen of the most disabling conditions as reported by the Centers for Disease Control 
were also collected. Overall work and activity impairment estimates were calculated 
for both the full sample and each of the nineteen diagnoses. Results: In total, 
50.7% of survey respondents were employed and provided information with respect 
to their work impairment; all respondents regardless of employment reported their 
activity impairment. These adults were an average 44.20 years old (SD= 13.52) and 
52.6% were male. The mean level of absenteeism, presenteeism, overall work impair-
ment, and activity impairment was 3.49%, 12.91%, 15.01%, and 22.08%, respectively 
(SDs= 13.88%, 21.98%, 24.96%, and 28.33%, respectively). The highest levels of over-
all work impairment were observed for patients with AIDS (42.7%), broken bones 
(36.6%), and hernia or rupture (32.8%) whereas the highest levels of activity impair-
ment were observed for patients with a hernia or rupture (53.9%), kidney problems 
(48.5%), and back or spine problems (47.5%). cOnclusiOns: These results help to 
provide some context for work and activity impairment by providing estimates for 
the overall population as well as for nineteen separate disease states/conditions.
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Objectives: The asthma quality of life questionnaire (AQLQ) is a condition-spe-
cific measure which evaluates four domains of health-related quality of life (HRQL) 
important in asthmatic adults: activity limitation, symptoms, emotional function, 
and environmental exposure. The objectives of this study were to identify: 1) How 
many HRQL claims were obtained in the label of asthma products using the AQLQ; 
2) HRQL measures used in trials but not mentioned in label; and 3) Reasons why 
to discard these measures. MethOds: The PROLabels database was searched on 
12/27/2014 using “asthma” as a key word for therapeutic indication. Results: Out 
of thirty-seven products approved for asthma (five by the EMA, and 32 by the FDA), 
twenty-five had PRO claims in their label. Five of them had a HRQL claim: Symbicort 
(budesonide/formoterol fumarate dehydrate - FDA), Advair HFA (fluticasone propi-
onate/salmeterol xinafoate - FDA), Advair Diskus (fluticasone propionate/salme-
terol xinafoate - FDA), Dulera (mometasone furoate/formoterol fumarate – FDA) 
and Xolair (omalizumab - EMA). In all cases, the HRQL evaluation was performed 
using the AQLQ. Of the 20 products with PROs in label (but not HRQL), seven had 
no HRQL evaluation performed, three had no medical review available, and ten 
had a HRQL evaluation using the AQLQ (n= 8), and/or the SF-36 (n= 3) [one product 
used both measures]. The main reasons provided for not including HRQL data in 
the label were lack of statistical significance between treatment groups, or not 
reaching clinical significance. In one case (omalizumab), the FDA argued about the 
improper use of the AQLQ. cOnclusiOns: This review has shown that all HRQL 
claims in asthma product labels were obtained using the AQLQ, a validated measure 
in asthma patients with a recognized minimally important difference enabling a 
clear interpretation of results. For these reasons the AQLQ could be considered as 
a potentially acceptable measure for regulatory qualification.
PRS42
RelAtionSHiP between HeAltH-RelAted inteRnet ACtivitieS And 
HeAltH-RelAted quAlity of life Among AStHmA PAtientS
Kanchanasuwan S., Wang Y., Young H.N.
University of Georgia, Athens, GA, USA
Objectives: To examine the relationships between health-related quality of life and 
use of Internet for health related activities among patients with asthma. MethOds: 
The 2009 National Health Interview Survey and 2010 Medical Expenditure Panel 
Survey were used to select the study sample; 523 adult patients with asthma (n= 
6,075,087 weighted). Health-related quality of life was the outcome of interest. The 
Andersen Model of Health Care Utilization was used to guide the selection of inde-
pendent variables. Predisposing factors, enabling factors, need factors, smoking 
status, and health-related Internet activities comprised the independent variables. 
Five health-related Internet activities included 1) seeking health information on the 
Internet, 2) use online chat group to learn about health, 3) refill a prescription on the 
Internet, 4) schedule an appointment with a health care provider using the Internet, 
and 5) communicate with a health care provider over email. Linear regression 
analyses, incorporating the sampling weights, were employed. All analyses were 
conducted using STATA (version 13.1). Results: Fifty percent of asthma patients 
reported performing at least one health-related Internet activity. The most reported 
activity was seeking health information on the Internet (49%). Mean physical com-
ponent summary (PCS-12) and mental component summary (MCS-12) in asthma 
patients were 49.52 (SD= 0.62) and 50.5 (SD= 0.52). After controlling for independent 
variables, only scheduling an appointment with a health care provider using the 
Internet was significantly related to the physical component summary score (β = 4.94, 
95% CI: 0.95 to 8.94). cOnclusiOns: Study Results suggest that the Internet plays a 
role in self-care and health-related quality of life among asthma patients. However, 
findings also indicate that asthma patients haven’t fully implemented using the 
Internet to accomplish all self-care tasks. Future research should examine the rela-
tionships between health-related Internet activities, health services utilization and 
outcomes.
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Objectives: Our study was aimed to assess the Influence of Demographic 
status on outcomes such as pulmonary function, medication adherence and 
health related quality of life (HRQoL) in COPD patients MethOds: An open 
which influence the treatment outcome in TB patients. cOnclusiOns: The present 
study concluded that majority of the TB patients had successful treatment out-
come, however, efforts should be made evaluate the treatment failure particularly 
in elderly patients to achieve better treatment outcomes.
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Patients with COPD experience lower levels of health related quality of life (HRQoL). 
Social and emotional support has been found to improve mental and physical 
health and reduce mortality. Few studies have investigated the impact of social 
and emotional support among patients with COPD. Objectives: To examine the 
impact of social and emotional support on HRQoL, disability and depression among 
COPD patients. MethOds: We utilized data from the 2013 Behavioral Risk Factor 
Surveillance System (BRFSS) to match self-reported COPD patients who receive 
emotional/social support (63%) with those who rarely/never (37%) receive that sup-
port based on a propensity score model. We used the STATA command psmatch2 
to perform 1:1 nearest neighbor matching without replacement, and caliper width 
was set at 0.01. Adequacy of matching was assessed by estimating the standardized 
differences between the matched pairs for all variables. We compared the HRQoL 
domains (general, physical, mental health and activity limitation), depression and 
disability for the matched cohort using the McNemar’s test. Results: After pro-
pensity score matching, standardized differences between groups were < 10% for all 
matched variables (demographics, smoking, exercise, and comorbidities), indicat-
ing adequate matching between each level of emotional support. COPD patients 
who rarely/never receive emotional/social support were more likely to experience 
more poor physical HRQoL days (n= 307 pairs, odds ratio (OR)= 2.13, 95% confidence 
interval (CI):1.52-3.03, p< 0.001), poor mental HRQoL days (n= 300 pairs ,OR= 1.59, 
CI:1.11-2.72, p= 0.007), days of activity limitations (n= 319 pairs, OR= 1.92, CI:1.4-2.7, 
p< 0.001) and depression (n= 321 pairs, OR= 1.59, CI:1.1-2.33, p < 0.001). Poor gen-
eral health and disability were not significantly associated with emotional/social 
support. cOnclusiOns: Among COPD patients, inadequate emotional and social 
support is associated with depression and impairments of most HRQoL domains. 
Recognition of the importance of emotional and social support by family members, 
healthcare providers and policy makers is important to improve functioning among 
COPD patients.
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Objectives: Chronic urticaria (chronic hives) can be inducible or spontaneous 
(CSU). Data supporting the impact of CSU on patients and comparisons with other 
dermatological diseases are scarce. This study evaluated the burden of illness 
associated with CSU relative to psoriasis (PsO) among adults across 5 European 
countries (EU) and the United States (US). MethOds: Data from respondents with 
a diagnosis of chronic hives (as proxy for CSU) or PsO were collected from the 
National Health and Wellness Survey (NHWS) in the EU (2010-2013) and US (2010-12). 
Humanistic burden was measured using SF-12v2 (2010-11) or SF-36v2 (2012-13) and 
health utility score (SF-6D). Self-reported anxiety, depression and sleep difficulty 
were also assessed. Comorbidity was measured using Charlson Comorbidity Index 
(CCI). Bivariate analysis (t-tests for continuous and chi-square tests for categorical 
variables) was used to compare CSU patients vs. PsO patients in EU and US, respec-
tively. Results: Study included 1,516 patients with CSU (769 EU; 747 US) and 12,964 
patients with PsO (7,857 EU; 5,107 US). CSU patients had lower (worse) mean mental 
(40.8 vs. 44.6) and physical component scores (45.2 vs. 47.4) and SF-6D score (0.64 
vs. 0.69), than PsO patients (p< 0.001 for all) in EU. Lower scores for CSU patients 
were also reported in US (44.7 vs. 47.0, 43.8 vs. 45.5 and 0.67 vs. 0.70, respectively, 
p< 0.001 for all). More CSU than PsO patients reported anxiety (45.4% vs.30.4%), 
depression (26.9% vs. 20.4%) and sleep difficulties (55.7% vs. 42.6%) both in EU and 
US (41.6% vs. 30.4%, 38.8% vs. 27.7%, and 49.9% vs. 40.3%, respectively) (p< 0.001 for 
all). Comorbidity burden was higher for CSU than PsO in EU (CCI= 0.90 vs. CCI= 0.50, 
respectively) and US (CCI= 1.05 vs. CCI= 0.78) (both, p< 0.001). cOnclusiOns: CSU 
is associated with significant detrimental impact on quality of life comparable or 
greater burden relative to PsO in EU and US.
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Objectives: Work and activity impairment represent important dimensions for 
assessing the burden of disease. However, unlike some other patient-reported out-
come measures, there are no population norms for work and activity impairment 
or studies that extensively compare impairment across conditions. The inability 
to compare against the broader population or to specific diseases or conditions 
can make it difficult for researchers to put the effect of a disease on impairment 
in a broader context. MethOds: Data came from the 2012 United States National 
Health and Wellness Survey (NHWS), a health survey of a nationally representative 
sample of adults (N= 71,141). The NHWS includes the Work Productivity and Activity 
Impairment (WPAI) questionnaire, which measures absenteeism, presenteeism, 
overall work impairment, and activity impairment. Self-reported diagnoses of nine-
